Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Christiane Copie Bergman, MDPhD, Elodie Bohers, PhD, Peggy Dartigues-Cuillères, MD, Pierre-Julien Viailly, Philippe Ruminy, PhD, Vinciane Marchand, Marie-Helene Delfau-Larue, Corinne Haioun, MDPhD, Cyrielle Robe, Elsa Poullot, MD, Steven Le Gouill, MD PhD, Yannick Le Bris, PharmD, Céline Bossard, MD, Anne Moreau, MD, Vincent Ribrag, MD, Valérie Camara-clayette, PhD, Cyril Quivoron, PhD, Gilles Salles, MDPhD, Sophie Cotteret, MD PhD, Pierre Sujobert, MD PhD, Alexandra Traverse-Glehen, MD PhD, Claire Mauduit, Pascaline Etancelin, Sarah Huet, Liana Veresezan, MD, Krimo Bouabdallah, MD, Marie Parrens, MD, Audrey Gros, PhD, Samuel Amintas, David Sibon, MD PhD, Ludovic Lhermitte, MD PhD, Thomas Steimle, Sophie Kaltenbach, Bettina Fabiani, MD, Camille Laurent, MD PhD, Barbara Burroni, Laurent Martin, MD PhD, Thierry Jo Molina, MDPhD, Lysa LYSARC study group, Fabrice Jardin, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141953

Published: 2020

Journal Articles

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Victor Bobée, PharmD, Fanny Drieux, MD, Vinciane Marchand, Vincent Sater, Liana Veresezan, MD, Jean-Michel Picquenot, MD, Pierre-Julien Viailly, Marie-delphine Lanic, Mathieu Viennot, Elodie Bohers, PhD, Lucie Oberic, MD, Christiane Copie-Bergman, MD PhD, Thierry Jo Molina, MD PhD, Philippe Gaulard, MD PhD, Corinne Haioun, MD PhD, Gilles A. Salles, MD PhD, Herve Tilly, MD PhD, Fabrice Jardin, Philippe Ruminy, PhD

Blood (2019) 134 (Supplement_1): 1476.

https://doi.org/10.1182/blood-2019-122405

Published: 2019

Journal Articles

Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa

Lucie Oberic, MD, Mathieu Puyade, MD, Frederic Peyrade, MD, Herve Maisonneuve, MD, Julie Abraham, Pierre Feugier, MD, Catherine Thieblemont, MD PhD, Gilles Salles, MD PhD, Fontanet Bijou, MD, Gian-Matteo Pica, MD, Philippe Ruminy, PhD, Peggy Dartigues-Cuillères, MD, Gandhi Damaj, MD PhD, Philippe Gaulard, MD PhD, Jean-François Emile, MD PhD, Bettina Fabiani, Herve Tilly, MD PhD, Corinne Haioun, MD PhD, Fabrice Jardin

Blood (2019) 134 (Supplement_1): 352.

https://doi.org/10.1182/blood-2019-123612

Published: 2019

Journal Articles

Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study)

Blood (2019) 134 (Supplement_1): 2765.

https://doi.org/10.1182/blood-2019-124444

Published: 2019

Journal Articles

A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 416.

https://doi.org/10.1182/blood.V130.Suppl_1.416.416

Published: 2017

Journal Articles

Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients

Blood (2017) 130 (Supplement 1): 309.

https://doi.org/10.1182/blood.V130.Suppl_1.309.309

Published: 2017

Journal Articles

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 4118.

https://doi.org/10.1182/blood.V128.22.4118.4118

Published: 2016

Journal Articles

Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

Fanny Drieux, MD, Philippe Ruminy, PhD, Virginie Fataccioli, PhD, Vinciane Marchand, Marie Parrens, MD PhD, Céline Bossard, MD, Pierre Julien Viailly, Maria Pamela Dobay, PhD, Elena Liana Veresezan, MD, Anais Pujals, PhD, Aurélie Dupuy, PhD, Jean-Michel Picquenot, MD, Hervé Tilly, MD PhD, Laurence de Leval, MD PhD, Fabrice Jardin, MD PhD, Philippe Gaulard, MD PhD

Blood (2016) 128 (22): 2932.

https://doi.org/10.1182/blood.V128.22.2932.2932

Published: 2016

Journal Articles

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Blood (2016) 128 (22): 4097.

https://doi.org/10.1182/blood.V128.22.4097.4097

Published: 2016

Journal Articles

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Blood (2015) 126 (23): 1472.

https://doi.org/10.1182/blood.V126.23.1472.1472

Published: 2015

Journal Articles

Somatic Mutations Detected in Plasma Cell-Free DNA By Targeted Sequencing: Assessment of Liquid Biopsy in Primary Central Nervous System Lymphoma

Maxime Fontanilles, Florent Marguet, Élodie Bohers, Pierre-Julien Viailly, Philippe Bertrand, PhD, Sydney Dubois, Sylvain Mareschal, Vincent Camus, Elena-Liana Veresezan, Philippe Ruminy, PhD, Hervé Tilly, MD PhD, Annie Laquerriere, Jean-Michel Picquenot, PhD, Fabrice Jardin, MD PhD

Blood (2015) 126 (23): 332.

https://doi.org/10.1182/blood.V126.23.332.332

Published: 2015

Journal Articles

Highly Multiplexed Targeted Sequencing of Recurrent Fusion Genes in Acute Leukemia

Blood (2014) 124 (21): 2335.

https://doi.org/10.1182/blood.V124.21.2335.2335

Published: 2014

Journal Articles

Targeted EZH2 Inhibitors in Diffuse Large B-Cell Lymphoma (DLBCL): Immunohistochemical and Mutational Profiles of Patients May Determine Candidates for Treatment

Sydney Dubois, Sylvain Mareschal, Marie Cornic, Jean-Michel Picquenot, MD, Philippe Bertrand, PhD, Elodie Bohers, PhD, Catherine Maingonnat, Pierre-Julien Viailly, Philippe Ruminy, PhD, Marion Alcantara, MD, Christian Bastard, MD, Fabrice Jardin, MD PhD, Herve Tilly, MD PhD

Blood (2014) 124 (21): 1656.

https://doi.org/10.1182/blood.V124.21.1656.1656

Published: 2014

Journal Articles

Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA Assay

Philippe Ruminy, PhD, Sylvain Mareschal, Cristina Bagacean, Vinciane Rainville, Karen Leroy, MD, Jean-Philippe Jais, MD, PhD, Hugo Varet, Martin Figeac, PhD, jean Michel Picquenot, MD, Herve Tilly, MD, Fabrice Jardin, MD, PhD

Blood (2013) 122 (21): 84.

https://doi.org/10.1182/blood.V122.21.84.84

Published: 2013

Journal Articles

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

Blood (2012) 120 (21): 1539.

https://doi.org/10.1182/blood.V120.21.1539.1539

Published: 2012

Journal Articles

Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Philippe Ruminy, PhD, Vinciane Rainville, Sylvain Mareschal, Pascaline Etancelin, Berangere Joly, Jean-Michel Picquenot, MD, Christian Bastard, MD, Herve Tilly, MD, Fabrice Jardin, MD, PhD

Blood (2012) 120 (21): 418.

https://doi.org/10.1182/blood.V120.21.418.418

Published: 2012

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

Genetic Reconstruction of Follicular Lymphoma Evolutions: Sμ Mutations Studies Suggest Two Progression Patterns, Early Direct or Late from FL “Stem Cells”.

Philippe Ruminy, PhD, Fabrice Jardin, MD, PhD, Françoise Parmentier, Nathalie Contentin, MD, Gérard Buchonnet, MD, PhD, Herve Tilly, MD, Christian Bastard, MD, PhD

Blood (2007) 110 (11): 182.

https://doi.org/10.1182/blood.V110.11.182.182

Published: 2007

Journal Articles

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Karin Tarte, PhD, Céline Pangault, PhD, John de Vos, MD, PhD, Philippe Ruminy, PhD, Fabienne Sauvee, Patrick Tas, MD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, PhD, Thierry Lamy, MD, PhD, Christian Bastard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 355.

https://doi.org/10.1182/blood.V110.11.355.355

Published: 2007

Journal Articles

A Quantitative Multiplex PCR Assay, Validated by a High Resolution Array Comparative Genomic Hybridization Analysis, Provides Information Regarding Genomic Imbalances and Prognosis in Diffuse Large B-Cell Lymphomas.

Fabrice Jardin, MD, PhD, Philippe Ruminy, PhD, Francoise Parmentier, Jean-pierre Kerckaert, PhD, Vinciane Rainville, Jean Michel Picquenot, MD, Gerard Buchonnet, MD, PhD, Dominique Penther, MD, Christian Bastard, MD, PhD, Herve Tilly, MD

Blood (2006) 108 (11): 815.

https://doi.org/10.1182/blood.V108.11.815.815

Published: 2006

NARROW

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa

Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study)

A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma

Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Somatic Mutations Detected in Plasma Cell-Free DNA By Targeted Sequencing: Assessment of Liquid Biopsy in Primary Central Nervous System Lymphoma

Highly Multiplexed Targeted Sequencing of Recurrent Fusion Genes in Acute Leukemia

Targeted EZH2 Inhibitors in Diffuse Large B-Cell Lymphoma (DLBCL): Immunohistochemical and Mutational Profiles of Patients May Determine Candidates for Treatment

Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA Assay

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Genetic Reconstruction of Follicular Lymphoma Evolutions: Sμ Mutations Studies Suggest Two Progression Patterns, Early Direct or Late from FL “Stem Cells”.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

A Quantitative Multiplex PCR Assay, Validated by a High Resolution Array Comparative Genomic Hybridization Analysis, Provides Information Regarding Genomic Imbalances and Prognosis in Diffuse Large B-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only